| scholarly article | Q13442814 |
| P2093 | author name string | Sarah Walker | |
| Robert Rees | |||
| James Harvey | |||
| Mark Burman | |||
| Anthony Lynch | |||
| Ayesha Siddiqui | |||
| Emma Nicholas | |||
| Michael Aylott | |||
| P433 | issue | 4 | |
| P304 | page(s) | 345-353 | |
| P577 | publication date | 2003-07-01 | |
| P1433 | published in | Mutagenesis | Q15724554 |
| P1476 | title | Investigations into the concept of a threshold for topoisomerase inhibitor-induced clastogenicity | |
| P478 | volume | 18 |
| Q24627296 | (-)-Epigallocatechin gallate, a major constituent of green tea, poisons human type II topoisomerases |
| Q37808574 | An overview of the visualisation and quantitation of low and high MW DNA adducts using the trapped in agarose DNA immunostaining (TARDIS) assay. |
| Q43244109 | Assessment of DNA double-strand breaks and gammaH2AX induced by the topoisomerase II poisons etoposide and mitoxantrone |
| Q37172950 | Background, approaches and recent trends for setting health-based occupational exposure limits: a minireview |
| Q24627367 | Bioflavonoids as poisons of human topoisomerase II alpha and II beta |
| Q28478263 | Characterization of Abcc4 gene amplification in stepwise-selected mouse J774 macrophages resistant to the topoisomerase II inhibitor ciprofloxacin |
| Q47756444 | Classification of in vitro genotoxicants using a novel multiplexed biomarker assay compared to the flow cytometric micronucleus test |
| Q49843069 | Cooperative p16 and p21 action protects female astrocytes from transformation |
| Q46612630 | Dexrazoxane mitigates epirubicin-induced genotoxicity in mice bone marrow cells |
| Q24642324 | Dietary polyphenols as topoisomerase II poisons: B ring and C ring substituents determine the mechanism of enzyme-mediated DNA cleavage enhancement |
| Q90611661 | Differentiation of Aneugens and Clastogens in the In Vitro Micronucleus Test by Kinetochore Scoring Using Automated Image Analysis |
| Q38810274 | Empirical analysis of BMD metrics in genetic toxicology part I: in vitro analyses to provide robust potency rankings and support MOA determinations |
| Q34095957 | Evaluating the genotoxicity of topoisomerase-targeted antibiotics |
| Q28473154 | Genistein-supplemented diet decreases malaria liver infection in mice and constitutes a potential prophylactic strategy |
| Q38878804 | Genotoxic potential of selected cytostatic drugs in human and zebrafish cells. |
| Q36763477 | In vitro approaches to develop weight of evidence (WoE) and mode of action (MoA) discussions with positive in vitro genotoxicity results |
| Q34836773 | In vitro genotoxicity of rocuronium bromide in human peripheral lymphocytes |
| Q35945993 | In vitro micronucleus assay scored by flow cytometry provides a comprehensive evaluation of cytogenetic damage and cytotoxicity |
| Q39632856 | N-methylpurine DNA glycosylase plays a pivotal role in the threshold response of ethyl methanesulfonate-induced chromosome damage |
| Q47144070 | Opinion of the Scientific Committee on a request from EFSA related to A Harmonised Approach for Risk Assessment of Substances Which are both Genotoxic and Carcinogenic |
| Q57555127 | Proliferating primary hepatocytes from the pUR288 lacZ plasmid mouse are valuable tools for genotoxicity assessment in vitro |
| Q53123576 | Quantitative approaches for assessing dose-response relationships in genetic toxicology studies. |
| Q53320366 | Quantitative assessment of cumulative carcinogenic risk for multiple genotoxic impurities in a new drug substance. |
| Q47157326 | Risk assessment for peri- and post-menopausal women taking food supplements containing isolated isoflavones |
| Q53231599 | The genotoxic and antigenotoxic effects of tannic acid in human lymphocytes. |
| Q37871420 | The in vitro MN assay in 2011: origin and fate, biological significance, protocols, high throughput methodologies and toxicological relevance |
| Q58125945 | Thresholds of Genotoxic and Non-Genotoxic Carcinogens |
| Q45351775 | Translational PK/PD modeling for cardiovascular safety assessment of drug candidates: Methods and examples in drug development. |
| Q33519661 | Understanding genetic toxicity through data mining: the process of building knowledge by integrating multiple genetic toxicity databases |
Search more.